Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma 
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment 
Walden Biosciences Highlights 2024 Accomplishments and 2025 
Coding and documentation for Y-90 radioembolization 
Three-pronged treatment improves prognosis for inoperable liver cancer | Science 
Advancing early actions in chronic kidney disease
ASTRAZENECA, together with three medical organisations and four diagnostic laboratory operators, has entered into a partnership for chronic kidney disease...
:max_bytes(150000):strip_icc()/pulmonaryembolismtreatment-GettyImages-1181263076-6eb8a362645b467fa1184b812fc64ac1.jpg)
Pulmonary Embolism: Treatment Options
A pulmonary embolism (PE) occurs when a blood clot (embolus) enters a pulmonary artery (blood vessel) in the lungs and...
Neurosurgery Programs | Norton Healthcare
Norton Neuroscience Institute is a regional leader in the field of neurosurgery. Our providers use leading-edge, minimally invasive procedures to...
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic...
What Should a Transplant-Inclusive Value-Based Kidney Care Model Include?
The CMS Center for Medicare & Medicaid Innovation (CMMI) has developed several value-based care models that address chronic kidney disease...
When blood thinners fail: Researching a new treatment for sepsis
Researcher Dr. Patricia Liaw and her team are are working closely with clinical teams at Hamilton Health Sciences on a...